Patents by Inventor Sean Harrison

Sean Harrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10302607
    Abstract: Analysis of chemically samples using gas chromatography (GC) separation with vacuum ultra-violet spectroscopy detection is described. One technique focuses on assigning a specific analysis methodology to each constituent in a sample. Constituents can elute from the GC by themselves or with other constituents, in which case a deconvolution is done using VUV spectroscopic data. In an exemplary embodiment, each constituent may be specifically included in an analysis method during a setup procedure, after which the same series of analyses are done on subsequent sample runs. The second approach essentially integrates an entire chromatogram by first reducing it into a series of analysis windows, or time slices, that are analyzed automatically. The analysis at each time slice determines the molecular constituents that are present as well as their contributions to the total response. Either approach can be used to quantify specific analytes or to do bulk classification.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: May 28, 2019
    Assignee: VUV Analytics, Inc.
    Inventors: Phillip Walsh, Dale A. Harrison, Sean H. Jameson, Jr.
  • Patent number: 10140660
    Abstract: Systems and methods for enforcing compliance with fiduciary responsibilities related to the administration of a retirement plan are disclosed. The systems and methods include accessing compliance requirements corresponding to the fiduciary responsibilities related to administration of the retirement plan by a fiduciary. Upon accessing the requirements, compliance tasks are extracted in an example implementation. Once compliance tasks are extracted from the requirements, due dates for the compliance tasks are determined based on dates associated with the compliance requirements, or in some examples based on date chosen by a fiduciary. The compliance tasks are then stored in a database, in an example. The systems and methods then monitor the one or more compliance tasks and send alerts based on monitored activities. Finally, in an example implementation, responses to the alerts are tracked to determine whether any follow up action needs to be triggered.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: November 27, 2018
    Assignee: Fiduciary Compliance Corp.
    Inventors: Larry E. Crocker, William Sean Harrison
  • Publication number: 20170293951
    Abstract: A system for automatic categorization and assessment of billing narratives has a semantic engine that classifies billing entries with descriptions expressed in natural language into standardized categories of activity and task objective. The classification is by machine learning methods via training data that is maintained, updated and extended as needed. A rules engine applies rules to the categorized invoice data to analyze the data, report violations to a user/consumer of billed services and to perform related calculations.
    Type: Application
    Filed: April 7, 2017
    Publication date: October 12, 2017
    Inventors: Ian Nolan, Alex Kelly, Ciaran Flood, Sean Harrison, Michael Dineen
  • Patent number: 7951950
    Abstract: Disclosed are CRTH2 inhibitors represented by Structural Formula (I): The values for the variables of Structural Formula (I) are provided herein.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: May 31, 2011
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Jeremy D. Little, Shomir Ghosh, Sean Harrison, Amy M. Elder, Christelle C. Renou, Kenneth G. Carson
  • Publication number: 20100250313
    Abstract: Systems and methods for enforcing compliance with fiduciary responsibilities related to the administration of a retirement plan are disclosed. The systems and methods include accessing compliance requirements corresponding to the fiduciary responsibilities related to administration of the retirement plan by a fiduciary. Upon accessing the requirements, compliance tasks are extracted in an example implementation. Once compliance tasks are extracted from the requirements, due dates for the compliance tasks are determined based on dates associated with the compliance requirements, or in some examples based on date chosen by a fiduciary. The compliance tasks are then stored in a database, in an example. The systems and methods then monitor the one or more compliance tasks and send alerts based on monitored activities. Finally, in an example implementation, responses to the alerts are tracked to determine whether any follow up action needs to be triggered.
    Type: Application
    Filed: March 24, 2009
    Publication date: September 30, 2010
    Applicant: Fiduciary Compliance Corp.
    Inventors: Larry E. Crocker, William Sean Harrison
  • Publication number: 20100088245
    Abstract: Systems and methods are described for developing studies such as clinical trials, including computer-assisted recruitment or selection of patients, clinical trial investigators, facilities, or clinical trial study sites. In certain examples, computer-processing of physician records scores physicians potential investigators, as determined from at least one physician characteristic, and the physician's proximity to the nearest clinical trial study site. Clinical trial study sites are also scored. In certain examples, at least one physician characteristic is used to score potential clinical trial study sites. Processes for engaging physicians and their patients in clinical trial studies are also described. Suitable patients can be contacted through their physicians or other caregivers to participate in the clinical trial study.
    Type: Application
    Filed: October 6, 2009
    Publication date: April 8, 2010
    Inventors: William Sean Harrison, Paul J. Smith
  • Patent number: 7664658
    Abstract: A method for the enabling or blocking of an operating mode in a medical diagnostic device enables the operating mode of the diagnostic device only after successful verification of the consumable material required for the operational mode. The consumable material is identified by a machine-readable identification tag, which is read off by a reading device.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: February 16, 2010
    Assignee: Siemens Aktiengesellschaft
    Inventors: Sean Harrison, Rainer Kuth
  • Publication number: 20080046378
    Abstract: A system and method of providing after sales support for medical systems is described. During the economic lifetime of a medical system, new or modified software modules may become available as a result of advances in medical knowledge or the technology of the medical system. Such updates or improvements may be provided to customers with suitable existing medical systems by making such modules available for licensing on a pay-per-use or a paid-up license basis. Information regarding the after sales support is maintained on a data base by the manufacturer and provided to customers over a wide-area network. The information may be customized on the basis of the existing configuration of the customer medical system to indicate the additional modules that are available.
    Type: Application
    Filed: August 18, 2006
    Publication date: February 21, 2008
    Inventors: Sean Harrison, Rainer Kuth
  • Publication number: 20070156707
    Abstract: A device and a method are disclosed for access to at least one information item, which relates to at least one medicament, by a user, in particular in a hospital. At least one mobile electronic appliance is provided for carrying by the user. The appliance includes a reading device which is designed for reading an electronically legible identification which identifies the medicament. The mobile appliance includes a data link to at least one appliance-internal and/or -external memory device in which the information relating to the medicament is stored in such a manner that it is made available to the user via the mobile appliance as a function of the reading of the electronically legible identification of the medicament.
    Type: Application
    Filed: December 19, 2006
    Publication date: July 5, 2007
    Inventors: Friedrich Fuchs, Sean Harrison, Robert Kagermeier, Rainer Kuth, Klaus Ludwig, Dietmar Sierk, Gerhard Weller
  • Patent number: 7211672
    Abstract: Disclosed herein are compounds represented by Structural Formula (I): (I), wherein the variables are defined herein. Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.
    Type: Grant
    Filed: October 3, 2003
    Date of Patent: May 1, 2007
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Shomir Ghosh, Amy M. Elder, Kenneth G. Carson, Kevin Sprott, Sean Harrison
  • Publication number: 20060241109
    Abstract: Disclosed are CRTH2 inhibitors represented by Structural Formula (I): The values for the variables of Structural Formula (I) are provided herein.
    Type: Application
    Filed: February 23, 2006
    Publication date: October 26, 2006
    Inventors: Jeremy Little, Shomir Ghosh, Sean Harrison, Amy Elder, Christelle Renou, Kenneth Carson
  • Publication number: 20060106061
    Abstract: Disclosed herein are compounds represented by Structural Formula (I): (I), wherein the variables are defined herein. Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.
    Type: Application
    Filed: December 20, 2005
    Publication date: May 18, 2006
    Inventors: Shomir Ghosh, Amy Elder, Kenneth Carson, Kevin Sprott, Sean Harrison
  • Publication number: 20050256158
    Abstract: Disclosed herein are compounds represented by Structural Formula (I) and (I-A): Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply “CRTH2” for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.
    Type: Application
    Filed: April 7, 2005
    Publication date: November 17, 2005
    Inventors: Shomir Ghosh, Amy Elder, Kenneth Carson, Kevin Sprott, Sean Harrison, Frederick Hicks, Christelle Renou, Dominic Reynolds
  • Publication number: 20050215880
    Abstract: A method for the enabling or blocking of an operating mode in a medical diagnostic device enables the operating mode of the diagnostic device only after successful verification of the consumable material required for the operational mode. The consumable material is identified by a machine-readable identification tag, which is read off by a reading device.
    Type: Application
    Filed: March 24, 2005
    Publication date: September 29, 2005
    Inventors: Sean Harrison, Rainer Kuth
  • Publication number: 20040082609
    Abstract: Disclosed herein are compounds represented by Structural Formula (I): 1
    Type: Application
    Filed: October 3, 2003
    Publication date: April 29, 2004
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Shomir Ghosh, Amy M. Elder, Kenneth G. Carson, Kevin Sprott, Sean Harrison